These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 18474575

  • 1. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
    Betriu C, Culebras E, Gómez M, López F, Rodríguez-Avial I, Picazo JJ.
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2686-90. PubMed ID: 18474575
    [Abstract] [Full Text] [Related]

  • 2. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV, Domínguez MC, Pallares JA, Perea EJ.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.
    Nagy E, Urbán E, Nord CE, ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria.
    Clin Microbiol Infect; 2011 Mar; 17(3):371-9. PubMed ID: 20456453
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.
    Aldridge KE, O'Brien M.
    J Clin Microbiol; 2002 Nov; 40(11):4349-52. PubMed ID: 12409429
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.
    Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1247-52. PubMed ID: 22203594
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y, Chen XF, Xie XL, Xiao M, Yang Y, Zhang G, Zhang JJ, Duan SM, Zhang Q, Zhang P, Tsui C, Xu YC.
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J, Lee Y, Kim M, Seo YH, Kim WH, Yong D, Jeong SH, Lee K, Chong Y.
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
    Goldstein EJ, Citron DM, Tyrrell KL, Leoncio ES, Merriam CV.
    Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
    Reig M, Campello MG, Baquero F.
    J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals.
    Hecht DW, Osmolski JR, O'Keefe JP.
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S357-60. PubMed ID: 8324147
    [Abstract] [Full Text] [Related]

  • 19. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
    Katsandri A, Papaparaskevas J, Pantazatou A, Petrikkos GL, Thomopoulos G, Houhoula DP, Avlamis A.
    J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
    [Abstract] [Full Text] [Related]

  • 20. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
    Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Yu V, Rihs J, Gorbach SL.
    Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.